| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11883-008-0025-Z |
| P698 | PubMed publication ID | 18417073 |
| P50 | author | Roger Yu | Q81097370 |
| P2093 | author name string | Abbas Ardehali | |
| Mohamad Navab | |||
| Ladan Vakili | |||
| Daniel Marelli | |||
| Babak Yekta | |||
| Navid Gharavi | |||
| P2860 | cites work | Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging | Q24676858 |
| Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial | Q28181984 | ||
| Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit | Q34248584 | ||
| Heme oxygenase-1: a novel drug target for atherosclerotic diseases? | Q34581346 | ||
| Identification of inflammatory gene modules based on variations of human endothelial cell responses to oxidized lipids | Q35036420 | ||
| Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse | Q35800759 | ||
| Apolipoprotein A-I mimetic peptides | Q36098714 | ||
| Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial | Q38398332 | ||
| D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes | Q40494361 | ||
| Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides | Q41334148 | ||
| Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine | Q41501243 | ||
| Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor/apolipoprotein A-I double-knockout mice on Western diet | Q42054024 | ||
| Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide | Q43664811 | ||
| A role for oxidized phospholipids in atherosclerosis | Q43686230 | ||
| Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol | Q43862770 | ||
| Influenza infection promotes macrophage traffic into arteries of mice that is prevented by D-4F, an apolipoprotein A-I mimetic peptide | Q44114720 | ||
| L-4F, an Apolipoprotein A-1 Mimetic, Dramatically Improves Vasodilation in Hypercholesterolemia and Sickle Cell Disease | Q44430974 | ||
| Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice | Q44936573 | ||
| Systemic rather than local heme oxygenase-1 overexpression improves cardiac allograft outcomes in a new transgenic mouse. | Q45934944 | ||
| An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null mice. | Q46119869 | ||
| Inflammation/oxidation in chronic rejection: apolipoprotein a-i mimetic peptide reduces chronic rejection of transplanted hearts. | Q46259868 | ||
| D-4F and statins synergize to render HDL antiinflammatory in mice and monkeys and cause lesion regression in old apolipoprotein E-null mice | Q46450296 | ||
| Cytoprotective gene HO-1 and chronic rejection in heart transplantation. | Q46460104 | ||
| D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes | Q46531373 | ||
| Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice. | Q46650186 | ||
| D-4F reduces EO6 immunoreactivity, SREBP-1c mRNA levels, and renal inflammation in LDL receptor-null mice fed a Western diet | Q46675074 | ||
| High-density lipoprotein modulates oxidized phospholipid signaling in human endothelial cells from proinflammatory to anti-inflammatory | Q46765374 | ||
| D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet | Q46948181 | ||
| When pouring water on the fire makes it burn brighter | Q47859969 | ||
| L-4F, an apolipoprotein A-1 mimetic, restores nitric oxide and superoxide anion balance in low-density lipoprotein-treated endothelial cells | Q48016340 | ||
| Differential effects of apolipoprotein A-I-mimetic peptide on evolving and established atherosclerosis in apolipoprotein E-null mice. | Q51620237 | ||
| Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide. | Q53667385 | ||
| Long-Term Treatment with the Apolipoprotein A1 Mimetic Peptide Increases Antioxidants and Vascular Repair in Type I Diabetic Rats | Q60684945 | ||
| Effect of end group blockage on the properties of a class A amphipathic helical peptide | Q70628260 | ||
| Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice | Q80317215 | ||
| P433 | issue | 2 | |
| P921 | main subject | lipoprotein | Q28350 |
| inflammation | Q101991 | ||
| P304 | page(s) | 171-176 | |
| P577 | publication date | 2008-04-01 | |
| P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
| P1476 | title | Proatherogenic high-density lipoprotein, vascular inflammation, and mimetic peptides | |
| P478 | volume | 10 |
| Q41935783 | CD36 in chronic kidney disease: novel insights and therapeutic opportunities |
| Q39178456 | Extra-virgin olive oil consumption reduces the age-related decrease in HDL and paraoxonase 1 anti-inflammatory activities |
| Q28481613 | HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach |
| Q35138355 | High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids |
| Q35760064 | In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide |
| Q50917457 | Lipid transfers to HDL are diminished in long-term bedridden patients: association with low HDL-cholesterol and increased inflammatory markers. |
| Q83888380 | Micellar electrokinetic chromatography profiles of human high-density lipoprotein phospholipids |
| Q38770565 | Novel biological therapies for the treatment of diabetic foot ulcers |
| Q28573029 | Oxidized high-density lipoprotein enhances inflammatory activity in rat mesangial cells |
| Q37666992 | Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease |
| Q44701235 | Separation of total lipids on human lipoproteins using surfactant-coated multiwalled carbon nanotubes as pseudostationary phase in capillary electrophoresis |
Search more.